Freenome FRNM
NASDAQ FRNM
$13.95 -0.14 (-0.99%)
As of: Aug 27, 2026 · 3:59 PM EDT

Freenome (FRNM) Cash from Investing Activities (2025 - 2026)

Freenome (FRNM) posted quarterly Cash from Investing Activities of $8.2 million for Q2 2026, up 2619.58% year-over-year from $300000.0 in Q2 2025, and up 2619.58% quarter-over-quarter from $300000.0 in Q2 2025.

Freenome (FRNM) Cash from Investing Activities (2025 - 2026) Analysis & Trends

Freenome's Cash from Investing Activities history runs 2 years deep, the most recent figure standing at $8.2 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities rose 2619.58% year-over-year to $8.2 million; the TTM figure through Jun 2026 stood at $8.2 million (changed N/A YoY), while the FY2025 annual figure was $600000.0, up 100.7% from the prior year.
  • Cash from Investing Activities for Q2 2026 stood at $8.2 million, up from $300000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $8.2 million in Q2 2026, with the low at $300000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 164.00 Mn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -10.15 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -63.43 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -77.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -381.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -25.50 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -122.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -1.94 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -366.20 Mn
10 Freenome 152.52 Mn 152.52 Mn - 8.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 8.16 Mn
Jun 30, 2026 8.16 Mn
Jun 30, 2025 300,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 300,000.00
Mar 31, 2025 300,000.00